Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?

被引：26
|
作者：
Stephan, Carsten [1 ]
Koepke, Thomas [2 ]
Semjonow, Axel [2 ]
Lein, Michael [1 ,3 ]
Deger, Serdar [1 ]
Schrader, Mark [1 ]
Miller, Kurt [1 ]
Jung, Klaus [1 ,3 ]
机构：
[1] Charite Univ Med Berlin, Dept Urol, D-10117 Berlin, Germany
[2] Univ Clin Munster, Dept Urol, Prostate Ctr, Munster, Germany
[3] Berlin Inst Urol Res, Berlin, Germany
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2009年 / 47卷 / 11期
关键词：
method comparison; prostate cancer; prostate-specific antigen; WHO PSA standards; 1ST INTERNATIONAL STANDARDS; MULTICENTER CLINICAL-TRIAL; ARTIFICIAL NEURAL-NETWORK; COMMERCIAL ASSAYS; CANCER-DETECTION; SERUM; BIOPSY; IMPACT; PERCENTAGE; BIAS;
D O I：
10.1515/CCLM.2009.285
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
Prostate-specific antigen (PSA) assay-dependent variations could result in misinterpretation of individual PSA values. Therefore, the situation for clinical interpretation of PSA or percent free PSA (%fPSA) results is complicated. This review summarizes the differences in various total PSA (tPSA) and free PSA (fPSA) assays, and results obtained using the new World Health Organization (WHO) calibrated Access assays from various studies. Method comparisons between the traditionally calibrated Hybritech PSA and fPSA assays and the new "standardized" WHO calibrated assays yield results that are similar to 25% lower for PSA and fPSA. A PSA cut-off of 3 or 3.1 mu g/L should be considered for WHO calibrated assays in order to achieve the same sensitivity/specificity profile as with a cutoff of 4 mu g/L in traditionally calibrated assays. The %fPSA cut-offs could be retained. Clin Chem Lab Med 2009;47:1325-31.
引用
收藏
页码：1325 / 1331
页数：7
相关论文
共 50 条
  • [1] Impact of free prostate-specific antigen on discordant measurement results of assays for total prostate-specific antigen
    Semjonow, A
    Oberpenning, F
    Brandt, B
    Zechel, C
    Brandau, W
    Hertle, L
    [J]. UROLOGY, 1996, 48 (6A) : 10 - 15
  • [2] 20-25% lower concentrations of total and free prostate-specific antigen (PSA) after calibration of PSA assays to the WHO reference materials - analysis of 1098 patients in four centers
    Stephan, Carsten
    Bangma, Chris
    Vignati, Giulio
    Bartsch, Georg
    Lein, Michael
    Lung, Klaus
    Philippe, Marianne
    Semjonow, Axel
    Catalona, William J.
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2009, 24 (02): : 65 - 69
  • [3] 20-25% Lower Concentrations of Total and Free Prostate-Specific Antigen (PSA) After Calibration of PSA Assays to the WHO Reference Materials-Analysis of 1098 Patients in Four Centers Comment
    Walsh, Patrick C.
    [J]. JOURNAL OF UROLOGY, 2010, 183 (01): : 163 - 163
  • [4] Comparison of prostate-specific antigen (PSA) measured by four combinations of free PSA and total PSA assays
    Junker, R
    Brandt, B
    Zechel, C
    Assmann, G
    [J]. CLINICAL CHEMISTRY, 1997, 43 (09) : 1588 - 1594
  • [5] Discordant performance of assays for free and total prostate-specific antigen in relation to the early detection of prostate cancer
    Blijenberg, BG
    Yurdakul, G
    Van Zelst, B
    Bangma, CH
    Wildhagen, MF
    Schröder, FH
    [J]. BJU INTERNATIONAL, 2001, 88 (06) : 545 - 550
  • [6] Effect of digital rectal examination and flexible cystoscopy on free and total prostate-specific antigen, and the percentage of free prostate-specific antigen -: Differences between two PSA assays
    Rodríguez-Rubio, FI
    Robles, JE
    González, A
    Arocena, J
    Sanz, G
    Díez-Caballero, F
    Martín-Marquina, A
    Berián, JM
    [J]. EUROPEAN UROLOGY, 1998, 33 (03) : 255 - 260
  • [7] Activity does not affect free and total prostate-specific antigen levels but lowers the free-to-total prostate-specific antigen ratio
    Ulman, C
    Buyukyazi, G
    Taneli, F
    Uyanik, BS
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2004, 32 (06) : 583 - 589
  • [8] Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology
    Roehrborn, CG
    Gregory, A
    Mcconnell, JD
    Sagalowsky, AI
    Wians, FH
    [J]. UROLOGY, 1996, 48 (6A) : 23 - 32
  • [9] Clinical evaluation of free PSA total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer
    Filella, X
    Alcover, J
    Molina, R
    Rodriguez, A
    Carretero, P
    Ballesta, AM
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1226 - 1229
  • [10] Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
    Liu, Xin
    Tang, Jie
    Fei, Xiang
    Li, Qiu-Yang
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2015, 44 (11) : 1466 - 1472
12345